Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Oliver

Showing results (151-160 of 158) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 158 results.
British Journal of Cancer|December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working PartyA Horwich, R T Oliver, P M Wilkinson, et al.
Cancer|November 15, 1980
Chemotherapy and immunotherapy for acute myelogenous leukemiaT A Lister, J M Whitehouse, R T Oliver, et al.
British Medical Journal|January 28, 1978
Combination chemotherapy for acute lymphoblastic leukaemia in adultsT A Lister, J M Whitehouse, M E Beard, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyS D Fosså, R T Oliver, S P Stenning, et al.
Cancer|October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working PartyS P Stenning, M C Parkinson, C Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working PartyG M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer TrialA Horwich, D T Sleijfer, S D Fosså, et al.
British Journal of Cancer|July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursS D Fosså, S P Stenning, A Gerl, et al.
Pageof 16

Showing results (151-160 of 158) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 158 results.
British Journal of Cancer|December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working PartyA Horwich, R T Oliver, P M Wilkinson, et al.
Cancer|November 15, 1980
Chemotherapy and immunotherapy for acute myelogenous leukemiaT A Lister, J M Whitehouse, R T Oliver, et al.
British Medical Journal|January 28, 1978
Combination chemotherapy for acute lymphoblastic leukaemia in adultsT A Lister, J M Whitehouse, M E Beard, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyS D Fosså, R T Oliver, S P Stenning, et al.
Cancer|October 8, 1998
Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working PartyS P Stenning, M C Parkinson, C Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working PartyG M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer TrialA Horwich, D T Sleijfer, S D Fosså, et al.
British Journal of Cancer|July 29, 1999
Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursS D Fosså, S P Stenning, A Gerl, et al.
Pageof 16